DCLK1 and cancer: Although these findings are interesting and offer therapeutic potentialities, future studies are required to assess whether DCLK1 marks cancer stem cells in primary human colon cancers and whether this marker really englobes the whole tumoral cell population endowed with tumor-initiating capacities.